X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-13 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.38 | -7,086 | 569,345 | -1% | -$9,757 | ||||||
2023-06-13 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.38 | -7,079 | 704,087 | -1% | -$9,748 | ||||||
| A | 2023-05-16 | NVTA | Wen Yafei | CFO | S - Sale | $1.20 | -43,452 | 700,297 | -6% | -$52,112 | |||||
2023-05-16 | NVTA | Knight Kenneth D. | CEO | S - Sale | $1.20 | -45,432 | 1,671,610 | -3% | -$54,487 | ||||||
2023-05-16 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.20 | -26,476 | 576,431 | -4% | -$31,753 | ||||||
2023-05-16 | NVTA | Wen Yafei | CFO | S - Sale | $1.99 | -43,452 | 700,297 | -6% | -$86,600 | ||||||
2023-05-16 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $1.20 | -21,559 | 354,748 | -6% | -$25,856 | ||||||
2023-05-16 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.20 | -26,476 | 711,166 | -4% | -$31,753 | ||||||
2023-03-13 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.41 | -2,625 | 437,642 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.41 | -2,625 | 447,907 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Wen Yafei | CFO | S - Sale | $1.41 | -2,625 | 443,749 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Knight Kenneth D. | CEO | S - Sale | $1.41 | -1,853 | 517,042 | 0% | -$2,613 | ||||||
| M | 2022-12-16 | NVTA | George Sean E | Dir | S - Sale | $2.05 | -55,979 | 732,677 | -7% | -$114,630 | |||||
2022-08-25 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $3.45 | -1,350 | 251,307 | -1% | -$4,658 | ||||||
2022-08-16 | NVTA | Brida Thomas | See Remarks | S - Sale | $4.55 | -7,048 | 386,267 | -2% | -$32,071 | ||||||
2022-08-16 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $4.55 | -7,048 | 396,532 | -2% | -$32,071 | ||||||
2022-08-16 | NVTA | George Sean E | Dir | S - Sale | $4.55 | -22,085 | 788,656 | -3% | -$100,493 | ||||||
2022-08-16 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $4.55 | -3,252 | 198,657 | -2% | -$14,798 | ||||||
| M | 2022-05-17 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $3.70 | -10,102 | 201,909 | -5% | -$37,363 | |||||
2022-05-17 | NVTA | Knight Kenneth D. | COO | S - Sale | $3.81 | -28,295 | 518,895 | -5% | -$107,807 | ||||||
2022-05-17 | NVTA | Brida Thomas | See Remarks | S - Sale | $3.81 | -6,098 | 393,315 | -2% | -$23,234 | ||||||
2022-05-17 | NVTA | George Sean E | Pres, CEO | S - Sale | $3.81 | -18,296 | 794,691 | -2% | -$69,710 | ||||||
2022-05-17 | NVTA | Wen Yafei | CFO | S - Sale | $3.81 | -17,042 | 344,374 | -5% | -$64,932 | ||||||
2022-05-17 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $3.81 | -6,098 | 403,580 | -1% | -$23,234 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |